Emma Niméus

9PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersCell development, proliferation and deathTumour immunologyRadiation therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 07, 2026
ESR1 mutations are associated with enhanced MTORC1 signaling in a context-dependent manner.

|Jul 30, 2026
Investigation of a Prostate Cancer Radiation Response Signature in the Breast Cancer SweBCG91RT Randomized Trial.

|Apr 26, 2025
Glucose-6-phosphate-dehydrogenase on old peroxisomes maintains self-renewal of epithelial stem cells after asymmetric cell division.

Hien Bui, Simon Andersson, Agustin Sola-Carvajal

|Feb 05, 2025
Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.

Rebecca J G Drake, Amalia H Landén, Erik Holmberg

|Apr 18, 2023
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial.

Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus

|Mar 28, 2023
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.

Moa Egelberg, Tommaso De Marchi, Gyula Pekar

Pageof 2

Frequent Collaborators

5 joint publications

Erik Holmberg

5 joint publications

Per Karlsson

5 joint publications

Fredrika Killander

5 joint publications

Tommaso de Marchi